Multiple myeloma:: Lusting for NF-κB

被引：61

作者：

Gilmore, Thomas D. ^{[1
]}

机构：

[1] Boston Univ, Dept Biol, Boston, MA 02215 USA

来源：

CANCER CELL | 2007年 / 12卷 / 02期

关键词：

D O I：

10.1016/j.ccr.2007.07.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：95 / 97

页数：3

共 11 条

[1]

ANNUZIATA CM, 2007, CANC CELL

[2] High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients [J].

Carrasco, DR ;

Tonon, G ;

Huang, YS ;

Zhang, YY ;

Sinha, R ;

Bin, F ;

Stewart, JP ;

Zhan, FG ;

Khatry, D ;

Protopopova, M ;

Protopopov, A ;

Sukhdeo, K ;

Hanamura, I ;

Stephens, O ;

Barlogie, B ;

Anderson, KC ;

Chin, L ;

Shaughnessy, JD ;

Brennan, C ;

DePinho, RA .

CANCER CELL, 2006, 9 (04) :313-325

[3] Mutations in the NF-κB signaling pathway:: implications for human disease [J].

Courtois, G. ;

Gilmore, T. D. .

ONCOGENE, 2006, 25 (51) :6831-6843

[4] MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo [J].

Hideshima, Teru ;

Neri, Paola ;

Tassone, Pierfranchesco ;

Yasui, Hiroshi ;

Ishitsuka, Kenji ;

Raje, Noopur ;

Chauhan, Dharminder ;

Podarl, Klaus ;

Mitsiades, Constantine ;

Dang, Lenny ;

Munshi, Nikhil ;

Richardson, Paul ;

Schenkein, David ;

Anderson, Kenneth C. .

CLINICAL CANCER RESEARCH, 2006, 12 (19) :5887-5894

[5] Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth [J].

Jourdan, Michel ;

Moreaux, Jerome ;

De Vos, John ;

Hose, Dirk ;

Mahtouk, Karene ;

Abouladze, Matthieu ;

Robert, Nicolas ;

Baudard, Marion ;

Reme, Thierry ;

Romanelli, Angela ;

Goldschmidt, Hartmut ;

Rossi, Jean-Francois ;

Dreano, Michel ;

Klein, Bernard .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (02) :160-168

[6]

KEATS JJ, 2007, CANC CELL

[7] Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib [J].

Mulligan, George ;

Mitsiades, Constantine ;

Bryant, Barb ;

Zhan, Fenghuang ;

Chng, Wee J. ;

Roels, Steven ;

Koenig, Erik ;

Fergus, Andrew ;

Huang, Yongsheng ;

Richardson, Paul ;

Trepicchio, William L. ;

Broyl, Annemiek ;

Sonneveld, Pieter ;

Shaughnessy, John D., Jr. ;

Bergsagel, P. Leif ;

Schenkein, David ;

Esseltine, Dixie-Lee ;

Boral, Anthony ;

Anderson, Kenneth C. .

BLOOD, 2007, 109 (08) :3177-3188

[8] New drugs for myeloma [J].

Richardson, Paul G. ;

Mitsiades, Constantine ;

Schlossman, Robert ;

Munshi, Nikhil ;

Anderson, Kenneth .

ONCOLOGIST, 2007, 12 (06) :664-689

[9] A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 [J].

Shaughnessy, John D. ;

Zhan, Fenghuang ;

Burington, Bart E. ;

Huang, Yongsheng ;

Colla, Simona ;

Hanamura, Ichiro ;

Stewart, James P. ;

Kordsmeier, Bob ;

Randolph, Christopher ;

Williams, David R. ;

Xiao, Yan ;

Xu, Hongwei ;

Epstein, Joshua ;

Anaissie, Elias ;

Krishna, Somashekar G. ;

Cottler-Fox, Michele ;

Hollmig, Klaus ;

Mohiuddin, Abid ;

Pineda-Roman, Mauricio ;

Tricot, Guido ;

van Rhee, Frits ;

Sawyer, Jeffrey ;

Alsayed, Yazan ;

Walker, Ronald ;

Zangari, Maurizio ;

Crowley, John ;

Barlogie, Bart .

BLOOD, 2007, 109 (06) :2276-2284

[10] Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities [J].

Trecca D. ;

Guerrini L. ;

Fracchiolla N.S. ;

Pomati M. ;

Baldini L. ;

Maiolo A.T. ;

Neri A. .

Oncogene, 1997, 14 (7) :791-799

← 1 2 →